格隆汇11月6日丨上海医药(601607.SH)公布,公司下属上海上药中西制药有限公司(简称“上药中西”)的枸橼酸托法替布缓释片(简称“该药品”)收到国家药品监督管理局颁发的《药品注册证书》(证书编号:2025S03257),该药品获得批准生产。枸橼酸托法替布缓释片用于治疗类风湿关节炎、银屑病关节炎和强直性脊柱炎。根据国家相关政策,按新注册分类获批仿制药的品种在医保支付及医疗机构采购等领域将获得...
Source Link格隆汇11月6日丨上海医药(601607.SH)公布,公司下属上海上药中西制药有限公司(简称“上药中西”)的枸橼酸托法替布缓释片(简称“该药品”)收到国家药品监督管理局颁发的《药品注册证书》(证书编号:2025S03257),该药品获得批准生产。枸橼酸托法替布缓释片用于治疗类风湿关节炎、银屑病关节炎和强直性脊柱炎。根据国家相关政策,按新注册分类获批仿制药的品种在医保支付及医疗机构采购等领域将获得...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.